Cargando…

How Methodologic Differences Affect Results of Economic Analyses: A Systematic Review of Interferon Gamma Release Assays for the Diagnosis of LTBI

INTRODUCTION: Cost effectiveness analyses (CEA) can provide useful information on how to invest limited funds, however they are less useful if different analysis of the same intervention provide unclear or contradictory results. The objective of our study was to conduct a systematic review of method...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oxlade, Olivia, Pinto, Marcia, Trajman, Anete, Menzies, Dick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591384/ https://www.ncbi.nlm.nih.gov/pubmed/23505412 http://dx.doi.org/10.1371/journal.pone.0056044

Ejemplares similares

Patients' Costs and Cost-Effectiveness of Tuberculosis Treatment in DOTS and Non-DOTS Facilities in Rio de Janeiro, Brazil
por: Steffen, Ricardo, et al.
Publicado: (2010)

Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence
por: Trajman, A., et al.
Publicado: (2013)

1377. Use of Interferon-Gamma Release Assays (IGRAs) Reduced Latent Tuberculosis Infection (LTBI) Diagnosis in Refugee and Immigrant Children
por: Kushner, Lauren E, et al.
Publicado: (2019)

Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2022)

Effects of programmatic interventions to improve the management of latent tuberculosis: a follow up study up to five months after implementation
por: Yanes-Lane, Mercedes, et al.
Publicado: (2021)

Frequency of indeterminate results from an interferon-gamma release assay among HIV-infected individuals
por: de Oliveira, Sandra Maria do Valle Leone, et al.
Publicado: (2017)

TB Screening in Canadian Health Care Workers Using Interferon-Gamma Release Assays
por: Zwerling, Alice, et al.
Publicado: (2012)

GeneXpert or chest-X-ray or tuberculin skin testing for household contact assessment (GXT): protocol for a cluster-randomized trial
por: Trajman, Anete, et al.
Publicado: (2022)

Trajectories of tuberculosis-specific interferon-gamma release assay responses among medical and nursing students in rural India
por: Zwerling, Alice, et al.
Publicado: (2013)

Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis
por: Campbell, Jonathon R, et al.
Publicado: (2020)

Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis
por: Uppal, Aashna, et al.
Publicado: (2021)

Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population
por: Lee, Seung Heon, et al.
Publicado: (2015)

Correction: The impact of the Brazilian family health on selected primary care sensitive conditions: A systematic review
por: Bastos, Mayara Lisboa, et al.
Publicado: (2017)

The impact of the Brazilian family health on selected primary care sensitive conditions: A systematic review
por: Bastos, Mayara Lisboa, et al.
Publicado: (2017)

The Use of Interferon Gamma Release Assays in the Diagnosis of Active Tuberculosis
por: Vesenbeckh, Silvan M., et al.
Publicado: (2012)

Interferon-Gamma Release Assay Performance in Pulmonary and Extrapulmonary Tuberculosis
por: Feng, Yun, et al.
Publicado: (2012)

1760. Interferon Gamma Release Assay for Diagnosis of Lyme disease
por: Hefter, Yosefa, et al.
Publicado: (2018)

Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2018)

The Global Expansion of LTBI Screening and Treatment Programs: Exploring Gaps in the Supporting Economic Evidence
por: Kota, Nokwanda Thandeka, et al.
Publicado: (2023)

Cost-Effectiveness of Quantiferon®-TB Gold-In-Tube Versus Tuberculin Skin Testing for Contact Screening and Treatment of Latent Tuberculosis Infection in Brazil
por: Steffen, Ricardo Ewbank, et al.
Publicado: (2013)

Modeling the impact of tuberculosis interventions on epidemiologic outcomes and health system costs
por: Oxlade, Olivia, et al.
Publicado: (2015)

Non-Tuberculous Mycobacteria and the Performance of Interferon Gamma Release Assays in Denmark
por: Hermansen, Thomas Stig, et al.
Publicado: (2014)

Effects of acute critical illnesses on the performance of interferon-gamma release assay
por: Huang, Chun-Ta, et al.
Publicado: (2016)

Interferon gamma release assay and tuberculin skin test positivity in sarcoidosis
por: Vyas, Sunil, et al.
Publicado: (2015)

Population tailored modification of tuberculosis specific interferon-gamma release assay
por: Horvati, Kata, et al.
Publicado: (2016)

Interferon-Gamma Release Assay in a Patient with Tuberculosis Verrucosa Cutis
por: Kim, Geon, et al.
Publicado: (2015)

Accuracy of interferon gamma release assays for the COVID-19 immunity assessment
por: Stieber, Francis, et al.
Publicado: (2022)

Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population
por: Yang, Ying, et al.
Publicado: (2022)

622. Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis
por: Xu, Helen, et al.
Publicado: (2023)

Tuberculosis preventive treatment in people living with HIV—Is the glass half empty or half full?
por: Oxlade, Olivia, et al.
Publicado: (2021)

Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis
por: Ang, M, et al.
Publicado: (2012)

Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays
por: Corbière, Véronique, et al.
Publicado: (2012)

The Usefulness of Interferon-gamma Release Assay for Diagnosis of Tuberculosis-related Uveitis in Korea
por: Ahn, Seong Joon, et al.
Publicado: (2014)

Diagnostic Performance of Interferon-Gamma Releasing Assay in HIV-Infected Patients in China
por: Yu, Yanhua, et al.
Publicado: (2013)

251 Interferon-Gamma Release Assay—Useful Tool for the Diagnosis of Pleural Tuberculosis
por: Ondrejkova, Andrea, et al.
Publicado: (2012)

Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System
por: Pinto, Márcia, et al.
Publicado: (2015)

Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV
por: Steffen, Ricardo E., et al.
Publicado: (2020)

Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial
por: Oxlade, Olivia, et al.
Publicado: (2019)

The Distribution Frequency of Interferon-Gamma Receptor 1 Gene Polymorphisms in Interferon-γ Release Assay-Positive Patients
por: Chen, Changguo, et al.
Publicado: (2017)

Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
por: Tseng, Chia-Lin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mp2nm466kt4gv91rsiik29v6n6